Table 1.
Sample sources.
| assay | sample | case | source | time |
|---|---|---|---|---|
| iTRAQ analysis | HCC cases | 10 | a | 2013 |
| chronic hepatitis B cases | 10 | |||
| liver fibrosis cases | 10 | |||
| health controls | 10 | |||
| MRM verification | HCC cases | 24 | b | 2014 |
| chronic hepatitis B cases | 10 | a | ||
| liver cirrhosis cases | 10 | a | ||
| health controls | 13 | a | ||
| Immunohistochemistry assay | HCC and adjacent tissues | 80 | b | 2014 |
| ELISA verification | HCC cases | 290 | b | 2013–2018 |
| chronic hepatitis B cases | 202 | c | ||
| health controls | 269 | a |
iTRAQ, isobaric tags for the relative and absolute quantization; MRM, multiple reaction monitoring; ELISA, enzyme-linked immunosorbent assay; a, the First Affiliated Hospital of Guangxi Medical University; b, the Affiliated Tumor Hospital of Guangxi Medical University; c, the 8th Affiliated Hospital of Guangxi Medical University.